{"id":"NCT05082116","sponsor":"Novo Nordisk A/S","briefTitle":"Efficacy and Safety of Turoctocog Alfa Pegol (N8-GP) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A (pathfinder10)","officialTitle":"A Multi-centre, Open-label Trial Evaluating Efficacy, Safety and Pharmacokinetics of Turoctocog Alfa Pegol (N8-GP) When Used for Treatment and Prophylaxis of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-09-27","primaryCompletion":"2022-12-28","completion":"2022-12-28","firstPosted":"2021-10-18","resultsPosted":"2024-01-18","lastUpdate":"2024-12-16"},"enrollment":36,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Haemophilia A"],"interventions":[{"type":"DRUG","name":"turoctocog alfa pegol (N8-GP)","otherNames":[]}],"arms":[{"label":"N8-GP prophylaxis","type":"EXPERIMENTAL"}],"summary":"The study investigates how well the medicine called turoctocog alfa pegol (N8-GP) works in previously treated Chinese patients with severe haemophilia A.\n\nParticipants will be treated with N8-GP. This is a medicine that doctors can already prescribe in other countries.\n\nThe medicine will be injected into a vein (intravenous injections) and blood samples will be collected.\n\nThe study will last for about 7-8 months. Participants will have between 8 and 15 visits to the clinic and possibly a number of phone calls with the study doctor.","primaryOutcome":{"measure":"Number of Bleeding Episodes Per Year (Annualised Bleeding Rate)","timeFrame":"From start of treatment (Week 0) until Week 28","effectByArm":[{"arm":"Adolescents (12-17 Years)","deltaMin":0,"sd":null},{"arm":"Adults (18-70 Years)","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":14},"locations":{"siteCount":8,"countries":["China"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":13},"commonTop":["Weight decreased","Hyperuricaemia","Pyrexia","Upper respiratory tract infection","Abdominal discomfort"]}}